Tradestie Institutional Equity Comparison Engine

IMDX vs XBIO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

XBIO Overall Edge

XBIO Captures Institutional Edge (3โ€“0 Pillars ยท 3โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Xenetic Biosciences, Inc. (XBIO) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, IMDX trades at N/M Forward P/E with -1883.2% operating margin (+115.0% YoY revenue) versus XBIO at N/M Forward P/E and -81.0% operating margin (+12.0% YoY). In options structure, IMDX sits in BREAKDOWN (12th %ile IV; Dealer Gamma Walls on Pro) against XBIO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
IMDX N/M vs XBIO N/M Fwd P/E
Growth & Margin Winner XBIO
Op Margin -1883.2% vs -81.0% ยท YoY +115.0% vs +12.0%
Momentum & Technical Winner XBIO
1Y -73.8% vs -40.1% ยท 52W Pos 3% vs 3%
Options & Structure Winner XBIO
BREAKDOWN (12th %ile IV) vs UNCLASSIFIED (N/A IV)
IMDX NASDAQ
Insight Molecular Diagnostics Inc. Common Stock
In Vitro & In Vivo Diagnostic Substances
$1.66
+4.4% 1D
Market Cap $52.1M
1M Return -45.03%
1Y Return -73.78%
Forward P/E N/M
Unified AI Score
45.5 / 100 HOLD
Tech 50.0 Fund 40.0 Flow 58.0 Mom 40.0
XBIO NASDAQ
Xenetic Biosciences, Inc.
Pharmaceutical Preparations
$1.54
+0.65% 1D
Market Cap $3.6M
1M Return -23.76%
1Y Return -40.08%
Forward P/E N/M
Unified AI Score
52.8 / 100 HOLD
Tech 58.0 Fund 53.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IMDX -73.78% XBIO -40.08% Spread: +33.7 pp (XBIO Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period IMDX Revenue XBIO Revenue IMDX Op. Margin XBIO Op. Margin Margin Edge
FY2017 N/A $10M N/A -47.1% XBIO
FY2019 N/A $0M N/A -75511.7% XBIO
FY2020 $0M $0M -2443.3% -3189.8% IMDX
FY2021 $0M $0M -2444.3% -495.1% XBIO
FY2022 $0M $0M -1878.6% -393.6% XBIO
FY2023 $0M $0M -1672.4% -177.8% XBIO
FY2024 $0M $0M -3245.1% -168.2% XBIO
FY2025 $0M $0M -1260.8% -95.2% XBIO

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IMDX (4) vs XBIO (3)
Institutional Metric IMDX XBIO Criterion Row Winner
Market Capitalization Scale $52.1M $3.6M Larger Scale IMDX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +115.0% +12.0% Higher Growth IMDX
Operating Margin (TTM) Profitability -1883.2% -81.0% Higher Margin XBIO
Net Profit Margin Profitability 0.0% -75.9% Higher Margin IMDX
Return on Equity (ROE) Capital Efficiency -23603.1% -47.0% Higher ROE XBIO
52-Week Range Position Momentum 3% ($2โ€“$8) 3% ($1โ€“$5) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 2.91ฮฒ ยท 76% Vol 1.54ฮฒ ยท 99% Vol Lower Realized Risk IMDX
Unified Institutional Score Composite Signal 45.5 / 100 (HOLD) 52.8 / 100 (HOLD) Higher Composite XBIO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IMDX vs XBIO Buy Guide
IMDX BREAKDOWN
117d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 12th %ile
IV Regime Compressed (<25th %ile)
Live IMDX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
XBIO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live XBIO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IMDX nor XBIO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.